Jordan CT - Search Results

1

Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biology.

Guzman ML, Jordan CT. Guzman ML, et al. Among authors: jordan ct. Cancer Cell. 2009 Apr 7;15(4):252-4. doi: 10.1016/j.ccr.2009.03.008. Cancer Cell. 2009. PMID: 19345324 Free article.

2

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL. Jordan CT, et al. Leukemia. 2000 Oct;14(10):1777-84. doi: 10.1038/sj.leu.2401903. Leukemia. 2000. PMID: 11021753

3

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.

Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT. Guzman ML, et al. Among authors: jordan ct. Blood. 2001 Apr 1;97(7):2177-9. doi: 10.1182/blood.v97.7.2177. Blood. 2001. PMID: 11264190 Free article.

4

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT. Guzman ML, et al. Among authors: jordan ct. Blood. 2001 Oct 15;98(8):2301-7. doi: 10.1182/blood.v98.8.2301. Blood. 2001. PMID: 11588023 Free article.

5

Preferential induction of apoptosis for primary human leukemic stem cells.

Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, Jordan CT. Guzman ML, et al. Among authors: jordan ct. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16220-5. doi: 10.1073/pnas.252462599. Epub 2002 Nov 25. Proc Natl Acad Sci U S A. 2002. PMID: 12451177 Free PMC article.

6

Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.

Topisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT, Borden KL. Topisirovic I, et al. Among authors: jordan ct. Mol Cell Biol. 2003 Dec;23(24):8992-9002. doi: 10.1128/MCB.23.24.8992-9002.2003. Mol Cell Biol. 2003. PMID: 14645512 Free PMC article.

7

Considerations for targeting malignant stem cells in leukemia.

Guzman ML, Jordan CT. Guzman ML, et al. Among authors: jordan ct. Cancer Control. 2004 Mar-Apr;11(2):97-104. doi: 10.1177/107327480401100216. Cancer Control. 2004. PMID: 15024346 Free article. Review.

8

Mechanisms controlling pathogenesis and survival of leukemic stem cells.

Jordan CT, Guzman ML. Jordan CT, et al. Oncogene. 2004 Sep 20;23(43):7178-87. doi: 10.1038/sj.onc.1207935. Oncogene. 2004. PMID: 15378078 Review.

9

Cancer stem cell biology: from leukemia to solid tumors.

Jordan CT. Jordan CT. Curr Opin Cell Biol. 2004 Dec;16(6):708-12. doi: 10.1016/j.ceb.2004.09.002. Curr Opin Cell Biol. 2004. PMID: 15530785 Review.

10

Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels.

Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL. Topisirovic I, et al. Among authors: jordan ct. Mol Cell Biol. 2005 Feb;25(3):1100-12. doi: 10.1128/MCB.25.3.1100-1112.2005. Mol Cell Biol. 2005. PMID: 15657436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters